Hindukush Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 04-01-2025
- Paid Up Capital ₹ 7.50 M
as on 04-01-2025
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 8.80 Cr
as on 04-01-2025
- Satisfied Charges ₹ 7.90 Cr
as on 04-01-2025
About Hindukush Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹8.80 Cr. The company has closed loans amounting to ₹7.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amandeep Vohra and Mankamal Singh serve as directors at the Company.
- CIN/LLPIN
U24100UP2021PTC142930
- Company No.
142930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2021
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hindukush Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amandeep Vohra  | Director | 05-Mar-2021 | Current |
| Mankamal Singh | Director | 04-Jan-2023 | Current |
Financial Performance of Hindukush Pharmaceuticals.
Enhance accessibility to Hindukush Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hindukush Pharmaceuticals?
Unlock access to Hindukush Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hindukush Bioproducts Private LimitedActive 8 years 19 daysAmandeep Vohra and Mankamal Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Jul 2023 | ₹8.50 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Dec 2021 | ₹3.00 M | Open |
State Bank Of India Creation Date: 31 Mar 2021 | ₹7.90 Cr | Satisfied |
How Many Employees Work at Hindukush Pharmaceuticals?
Hindukush Pharmaceuticals has a workforce of 10 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindukush Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindukush Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
